Antithrombin Regulates Matriptase Activity Involved in Plasmin Generation, Syndecan Shedding, and HGF Activation in Keratinocytes

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Chen, Ya Wen ^a   Xu, Zhenghong ^a   Baksh, Adrienne N H ^b   Wang, Jehng Kang ^c   Chen, Chiu Yuan ^d   Swanson, Richard ^b   Olson, Steve T ^b   Kataoka, Hiroaki ^e   Johnson, Michael D ^f   Lin, Chen Yong ^a,f  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d NANHUA UNIVERSITY   (Taiwan)

^e UNIVERSITY OF MIYAZAKI   (Japan)

^f GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; HEPARIN; LYSINE; PLASMINOGEN; SCATTER FACTOR; SERINE PROTEINASE INHIBITOR; SYNDECAN 1;

ARTICLE; BINDING SITE; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME SUBSTRATE; ENZYME SYNTHESIS; GLYCOSYLATION; HUMAN; HUMAN CELL; KERATINOCYTE; PLASMINOGEN ACTIVATION; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN PROCESSING;

ANTITHROMBINS; BINDING SITES; CELL LINE; EPITHELIAL CELLS; FEMALE; FIBRINOLYSIN; GENE EXPRESSION REGULATION; HEPARIN; HEPATOCYTE GROWTH FACTOR; HUMANS; KERATINOCYTES; MALE; MAMMARY GLANDS, HUMAN; ORGAN SPECIFICITY; PROSTATE; PROTEIN BINDING; PROTEINASE INHIBITORY PROTEINS, SECRETORY; SERINE ENDOPEPTIDASES; SYNDECANS;

EID: 84877665556     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062826     Document Type: Article

References (51)

1. Eckert RL, (1989) Structure, function, and differentiation of the keratinocyte. Physiol Rev 69: 1316-1346.
2. Elias PM, Friend DS, McNutt NS, (1987) Epidermal permeability barrier: transformation of lamellar granule-disks into intercellular sheets by a membrane fusion process. J Invest Dermatol 88: 459-460.
3. Zeeuwen PL, (2004) Epidermal differentiation: the role of proteases and their inhibitors. Eur J Cell Biol 83: 761-773.
4. Ovaere P, Lippens S, Vandenabeele P, Declercq W, (2009) The emerging roles of serine protease cascades in the epidermis. Trends Biochem Sci 34: 453-463.
5. Oberst MD, Williams CA, Dickson RB, Johnson MD, Lin CY, (2003) The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor. J Biol Chem 278: 26773-26779.
6. Chen YW, Wang JK, Chou FP, Chen CY, Rorke EA, et al. (2010) Regulation of the matriptase-prostasin cell surface proteolytic cascade by hepatocyte growth factor activator inhibitor-1 (HAI-1) during epidermal differentiation. J Biol Chem 285: 31755-31762.
7. Chen CJ, Wu BY, Tsao PI, Chen CY, Wu MH, et al. (2011) Increased matriptase zymogen activation in inflammatory skin disorders. Am J Physiol Cell Physiol 300: C406-415.
8. Tseng IC, Xu H, Chou FP, Li G, Vazzano AP, et al. (2010) Matriptase activation, an early cellular response to acidosis. J Biol Chem 285: 3261-3270.
9. Netzel-Arnett S, Currie BM, Szabo R, Lin CY, Chen LM, et al. (2006) Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation. J Biol Chem 281: 32941-32945.
10. Xu H, Xu Z, Tseng IC, Chou FP, Chen YW, et al. (2012) Mechanisms for the control of matriptase activity in the absence of sufficient HAI-1. Am J Physiol Cell Physiol 302: C453-C462.
11. Oberst MD, Chen LY, Kiyomiya KI, Williams CA, Lee MS, et al. (2005) Hepatocyte growth factor activator inhibitor 1 (HAI-1) regulates activation and expression of matriptase, a membrane-bound serine protease. Am J Physiol Cell Physiol 289: C462-C470.
12. List K, Haudenschild CC, Szabo R, Chen W, Wahl SM, et al. (2002) Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis. Oncogene 21: 3765-3779.
13. Leyvraz C, Charles RP, Rubera I, Guitard M, Rotman S, et al. (2005) The epidermal barrier function is dependent on the serine protease CAP1/Prss8. J Cell Biol 170: 487-496.
14. Nagaike K, Kawaguchi M, Takeda N, Fukushima T, Sawaguchi A, et al. (2008) Defect of Hepatocyte Growth Factor Activator Inhibitor Type 1/Serine Protease Inhibitor, Kunitz Type 1 (Hai-1/Spint1) Leads to Ichthyosis-Like Condition and Abnormal Hair Development in Mice. Am J Pathol 173: 1464-1475.
15. Lee SL, Dickson RB, Lin CY, (2000) Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J Biol Chem 275: 36720-36725.
16. Satomi S, Yamasaki Y, Tsuzuki S, Hitomi Y, Iwanaga T, et al. (2001) A role for membrane-type serine protease (MT-SP1) in intestinal epithelial turnover. Biochem Biophys Res Commun 287: 995-1002.
17. Szabo R, Rasmussen AL, Moyer AB, Kosa P, Schafer JM, et al. (2011) c-Met-induced epithelial carcinogenesis is initiated by the serine protease matriptase. Oncogene 30: 2003-2016.
18. Kilpatrick LM, Harris RL, Owen KA, Bass R, Ghorayeb C, et al. (2006) Initiation of plasminogen activation on the surface of monocytes expressing the type II transmembrane serine protease matriptase. Blood 108: 2616-2623.
19. Li Q, Ke F, Zhang W, Shen X, Xu Q, et al. (2011) Plasmin plays an essential role in amplification of psoriasiform skin inflammation in mice. PLoS One 6: e16483.
20. Blasi F, Carmeliet P, (2002) uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol 3: 932-943.
21. Green KA, Almholt K, Ploug M, Rono B, Castellino FJ, et al. (2008) Profibrinolytic effects of metalloproteinases during skin wound healing in the absence of plasminogen. J Invest Dermatol 128: 2092-2101.
22. Lund LR, Green KA, Stoop AA, Ploug M, Almholt K, et al. (2006) Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice. EMBO J 25: 2686-2697.
23. Romer J, Bugge TH, Pyke C, Lund LR, Flick MJ, et al. (1996) Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med 2: 287-292.
24. Kataoka H, Shimomura T, Kawaguchi T, Hamasuna R, Itoh H, et al. (2000) Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment. J Biol Chem 275: 40453-40462.
25. Lin CY, Anders J, Johnson M, Dickson RB, (1999) Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk. J Biol Chem 274: 18237-18242.
26. Lin CY, Wang JK, Torri J, Dou L, Sang QA, et al. (1997) Characterization of a novel, membrane-bound, 80-kDa matrix-degrading protease from human breast cancer cells. Monoclonal antibody production, isolation, and localization. J Biol Chem 272: 9147-9152.
27. Benaud C, Dickson RB, Lin CY, (2001) Regulation of the activity of matriptase on epithelial cell surfaces by a blood-derived factor. Eur J Biochem 268: 1439-1447.
28. Benaud C, Oberst M, Hobson JP, Spiegel S, Dickson RB, et al. (2002) Sphingosine 1-phosphate, present in serum-derived lipoproteins, activates matriptase. J Biol Chem 277: 10539-10546.
29. Stampfer MR, Bartley JC, (1985) Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[a]pyrene. Proc Natl Acad Sci U S A 82: 2394-2398.
30. Lee M-S, Kiyomiya K, Benaud C, Dickson RB, Lin CY, (2005) Simultaneous activation and HAI-1-mediated inhibition of matriptase induced at activation foci in immortal human mammary epithelial cells. Am J Physiol Cell Physiol 288: C932-C941.
31. Chou FP, Xu H, Lee MS, Chen YW, Richards OX, et al. (2011) Matriptase is inhibited by extravascular antithrombin in epithelial cells but not in most carcinoma cells. Am J Physiol Cell Physiol 301: C1093-C1103.
32. Subramanian SV, Fitzgerald ML, Bernfield M, (1997) Regulated shedding of syndecan-1 and-4 ectodomains by thrombin and growth factor receptor activation. J Biol Chem 272: 14713-14720.
33. Opal SM, Kessler CM, Roemisch J, Knaub S, (2002) Antithrombin, heparin, and heparan sulfate. Crit Care Med 30: S325-S331.
34. Schedin-Weiss S, Arocas V, Bock SC, Olson ST, Bjork I, (2002) Specificity of the basic side chains of Lys114, Lys125, and Arg129 of antithrombin in heparin binding. Biochemistry 41: 12369-12376.
35. Schedin-Weiss S, Desai UR, Bock SC, Gettins PG, Olson ST, et al. (2002) Importance of lysine 125 for heparin binding and activation of antithrombin. Biochemistry 41: 4779-4788.
36. Arocas V, Bock SC, Raja S, Olson ST, Bjork I, (2001) Lysine 114 of antithrombin is of crucial importance for the affinity and kinetics of heparin pentasaccharide binding. J Biol Chem 276: 43809-43817.
37. Ding K, Lopez-Burks M, Sanchez-Duran JA, Korc M, Lander AD, (2005) Growth factor-induced shedding of syndecan-1 confers glypican-1 dependence on mitogenic responses of cancer cells. J Cell Biol 171: 729-738.
38. Subramanian SV, Fitzgerald ML, Bernfield M, (1997) Regulated shedding of syndecan-1 and-4 ectodomains by thrombin and growth factor receptor activation. J Biol Chem 272: 14713-14720.
39. Tseng IC, Chou FP, Su SF, Oberst M, Madayiputhiya N, et al. (2008) Purification from human milk of matriptase complexes with secreted serpins: mechanism for inhibition of matriptase other than HAI-1. Am J Physiol Cell Physiol 295: C423-C431.
40. Takeuchi T, Harris JL, Huang W, Yan KW, Coughlin SR, et al. (2000) Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J Biol Chem 275: 26333-26342.
41. Kirchhofer D, Peek M, Li W, Stamos J, Eigenbrot C, Kadkhodayan S, et al. (2003) Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1. J Biol Chem 278: 36341-36349.
42. Szabo R, Kosa P, List K, Bugge TH, (2009) Loss of Matriptase Suppression Underlies Spint1 Mutation-Associated Ichthyosis and Postnatal Lethality. Am J Pathol 174: 2015-2022.
43. Carney TJ, von der HS, Sonntag C, Amsterdam A, Topczewski J, et al. (2007) Inactivation of serine protease Matriptase1a by its inhibitor Hai1 is required for epithelial integrity of the zebrafish epidermis. Development 134: 3461-3471.
44. List K, Hobson JP, Molinolo A, Bugge TH, (2007) Co-localization of the channel activating protease prostasin/(CAP1/PRSS8) with its candidate activator, matriptase. J Cell Physiol 213: 237-245.
45. Wang JK, Lee MS, Tseng IC, Chou FP, Chen YW, et al. (2009) Polarized epithelial cells secrete matriptase as a consequence of zymogen activation and HAI-1-mediated inhibition. Am J Physiol Cell Physiol 297: C459-C470.
46. Myerburg MM, McKenna EE, Luke CJ, Frizzell RA, Kleyman TR, et al. (2008) Prostasin expression is regulated by airway surface liquid volume and is increased in cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 294: L932-L941.
47. Friis S, Godiksen S, Bornholdt J, Selzer-Plon J, Rasmussen HB, et al. (2011) Transport via the transcytotic pathway makes prostasin available as a substrate for matriptase. J Biol Chem 286: 5793-5802.
48. Manon-Jensen T, Itoh Y, Couchman JR, (2010) Proteoglycans in health and disease: the multiple roles of syndecan shedding. FEBS J 277: 3876-3889.
49. Kainulainen V, Wang H, Schick C, Bernfield M, (1998) Syndecans, heparan sulfate proteoglycans, maintain the proteolytic balance of acute wound fluids. J Biol Chem 273: 11563-11569.
50. Peterson CB, Blackburn MN, (1985) Isolation and characterization of an antithrombin III variant with reduced carbohydrate content and enhanced heparin binding. J Biol Chem 260: 610-615.
51. Swedenborg J, (1998) The mechanisms of action of alpha- and beta-isoforms of antithrombin. Blood Coagul Fibrinolysis 9Suppl 3: S7-10.